Stock Market Wealth
Become A Wealth Machine
KOIOS Beverage (US: KBEVF) – Expect FIREWORKS!
This is, without a doubt, a micro-cap opportunity to invest in the earliest stage possible in this company.
Since going public less than six months ago, KOIOS Beverage Corp (CSE: KBEV & US: KBEVF) has introduced a product line of several proprietary functional beverages.
Check these out:
When we looked into the differences between KOIOS products and their direct competitors, including those that Pepsi and Dr. Pepper/Snapple had paid hundreds of millions to buy out, we discovered that KeVita, which Pepsi paid $250M for, has 12-times the carbs amount that the KOIOS product has and Kevita’s drink lacks in nutritional value in major ways as well.
KeVita’s drinks are missing vitamins and natural extracts that KOIOS scientists have been able to blend into their formula – this technological advantage is critical.
The commercial benefits become even more apparent with the addition of MCT oils in KOIOS beverages: MCTs improve the above: blood sugar regulation, metabolism, thyroid function, and appetite regulation and are used to treat ailments including diabetes, Alzheimer’s, seizures, and cystic fibrosis.
KOIOS (CSE: KBEV & US: KBEVF) is the smallest company on the planet and one of the few to successfully add MCT oils to their products!
93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.
Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!
Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!
● Release acetylcholine, which increases attention capacity
● Provide nutrients for stronger than normal brain function
● Provide nerve growth and protection in the brain
● Create all-day mental clarity and energy
● Decrease the need for caffeine
The fact that the product line is already on shelves throughout the U.S and that a new hemp oil infused formula is being introduced to the market as we speak, along with the anticipated results of clinical trials, the legalization of cannabis in Canada, and the potential growth spurt in sales domestically, makes this tiny stock a massive opportunity at today’s prices.
This is the cheapest stock I’ve ever vetted, top to bottom, and it could turn out to be a slam dunk for us.
This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. Never base any decision off of our emails. wealthresearchgroup stock profiles are intended to be stock ideas, not recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by the company. We have also purchased shares and are long the company. Please use our site as a place to get ideas. Never make an investment decision off of anything we say. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.